KI researcher Qiang Pan-Hammarström elected to the Royal Swedish Academy of Sciences
Professor Qiang Pan-Hammarström at Karolinska Institutet is one of six new members of the Royal Swedish Academy of Sciences. Among other things, she has researched immunodeficiency diseases and worked to find treatments for covid-19.
Qiang Pan-Hammarström is Professor of Clinical Immunology at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet. Among other things, she has identified several genes that cause immunodeficiency diseases.
"I am deeply honored to be elected to the Royal Swedish Academy of Sciences. I am immensely grateful for the recognition and trust. I would also like to express my heartfelt gratitude to my trainees, collaborators, and family for their contributions and support to this journey. I look forward to working closely with my fellow academy colleagues to further promote science, especially medical science," says Qiang Pan-Hammarström.
In recent years, Qiang Pan-Hammarström has worked actively to find treatments for covid-19. The hope is that this will result in new medicines for immunocompromised patients who are not as well protected by vaccines.